[Cognitive decline in geriatric oncology: Trends, evaluation and treatment]
- PMID: 29773225
- DOI: 10.1016/j.bulcan.2018.04.006
[Cognitive decline in geriatric oncology: Trends, evaluation and treatment]
Abstract
Cancer prevalence increases with aging. Prevalent or incident neurocognitive disorders are frequent in geriatric oncology. Cognitive decline associated with cancer increases the risk of under or over-cancer treatment and makes therapeutic decisions complex. In this context, we present tools to optimize cognitive impairment screening, identification of underlying mechanisms and specific treatments. Geriatric specialists intervention can help global care, social services utilization and patient's orientation when ambulatory cares become difficult.
Keywords: Aging; Cancer; Cognitive decline; Confusion; Delirium; Déclin cognitif; Elderly; Geriatric assessment; Oncogériatrie; Vieillissement; Évaluation gériatrique.
Copyright © 2018 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
